Skip to main content
. 2016 Mar 31;6(3):e010126. doi: 10.1136/bmjopen-2015-010126

Table 2.

Characterisation of the multimorbid and non-multimorbid populations

Overall Multimorbidity
p Value
Yes (%) No
Number (%) 411 304 (74.0) 107 (26.0)
Haemoglobin (≤129 g/L) 183 (44.5) 146 (79.8) 37 (20.2 0.02
 Albumin, (≤35 g/L) 171 (41.6) 137 (80.1) 34 (19.9) 0.02
Polypharmacy (yes %) 279 (67.9) 240 (86.0) 39 (14.0) <0.0001
Frailty (Canadian Study of Health and Ageing scale)
 Very fit 73 (17.9) 32 (43.8) 41 (56.2) <0.0001
 Well 52 (12.8) 28 (53.8) 24 (46.2) Test for trend
Well, with comorbidity 89 (21.8) 72 (80.9) 17 (19.1)
Apparently vulnerable 81 (19.8) 65 (80.2) 16 (19.8)
 Mildly frail 56 (13.7) 49 (87.5) 7 (12.5)
 Moderately frail 41 (10.1) 39 (95.1) 2 (14.9)
 Severely frail 16 (3.9) 16 (100) 0
Operation (yes %) 79 (19.2) 55 (69.6) 24 (30.4) 0.33
 Minor or intermediate surgery 24 (34.3) 7 (29.2) 17 (70.8) 0.03
 Major or more severe surgery 46 (65.7) 41 (91.3) 4 (8.7)
Missing 9
Length of hospital stay (days, 95% CI) 9.3 (8.1 to 10.5) 9.1 (7.5 to 10.4) 9.8 (7.2 to 12.5) 0.29
 Readmission to hospital (yes %) 82 (19.9) 64 (78.0) 18 (22.0) 0.35
 Death within 30 days (yes %) 20 (4.9) 14 (70.0) 6 (30.0) 0.68
 Death within 90 days (yes %) 36 (8.8) 28 (77.8) 8 (22.2) 0.60